Clinical Trial Update: Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a phase 1/2 clinical trial evaluating ABI-007 (liposomal irinotecan) in combination with S-1 as second-line chemotherapy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• ABI-007 (nab-paclitaxel)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking University | Conditions: Gastric Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED